Clinical Efficacy of Modified Bazhentang Combined with Radiotherapy and Chemotherapy in Treating Middle and Advanced Cervical Cancer and Effect on T-cell Subset, Serum Tumor Markers and Survival

SONG Xiao-jie; ZHOU Yan-yan; ZHAO Li-na

doi:10.13422/j.cnki.syfjx.2018040174

您当前的位置：

首页 >

文章列表页 >

Clinical Efficacy of Modified Bazhentang Combined with Radiotherapy and Chemotherapy in Treating Middle and Advanced Cervical Cancer and Effect on T-cell Subset, Serum Tumor Markers and Survival

更新时间：2024-01-04

- Clinical Efficacy of Modified Bazhentang Combined with Radiotherapy and Chemotherapy in Treating Middle and Advanced Cervical Cancer and Effect on T-cell Subset, Serum Tumor Markers and Survival
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 4, Pages: 174-179(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2018040174
  CLC： R737.33
- Published：2018
- 稿件说明：
移动端阅览
SONG Xiao-jie, ZHOU Yan-yan, ZHAO Li-na. Clinical Efficacy of Modified Bazhentang Combined with Radiotherapy and Chemotherapy in Treating Middle and Advanced Cervical Cancer and Effect on T-cell Subset, Serum Tumor Markers and Survival[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(4): 174-179.
DOI：

SONG Xiao-jie, ZHOU Yan-yan, ZHAO Li-na. Clinical Efficacy of Modified Bazhentang Combined with Radiotherapy and Chemotherapy in Treating Middle and Advanced Cervical Cancer and Effect on T-cell Subset, Serum Tumor Markers and Survival[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(4): 174-179. DOI： 10.13422/j.cnki.syfjx.2018040174.

摘要

目的：探讨加味八珍汤联合放化疗对中晚期宫颈癌疗效及对患者T细胞亚群水平、血清肿瘤标志物表达及生存期的影响。方法：2009年2月—2012年5月河南省中医院共收治177例中晚期宫颈癌患者，以该批患者为研究对象，随机数字表法分为治疗组（89例），对照组（88例）。对照组采用同步放化疗法治疗，治疗组患者在此基础上加用加味八珍汤进行治疗，比较两组患者治疗后的近期疗效，T细胞亚群水平，血清肿瘤标志物表达及生存期。结果：治疗组患者总有效率为87.64%，对照组为73.86%，治疗组优于对照组（P<0.05）；经治疗，两组CD3+，CD4+水平，CD4+/CD8+均有明显上升，CD8+水平明显下降（P<0.05）；与对照组相比，治疗组CD3+，CD4+水平与CD4+/CD8+明显升高，CD8+水平明显降低（P<0.05）；经治疗，两组患者血清中糖链抗原125（carbohydrate antigen125，CA125），鳞状上皮癌相关抗原（squamous cell carcinoma associated antigen，SCCA）以及癌胚抗原（carcino-embryonic antigen，CEA）表达均明显降低（P<0.05），与对照组治疗后相比，治疗组上述指标明显降低（P<0.05）；治疗组患者1，2，3，5年生存率分别为91.01%，55.06%，26.97%，13.48%，相比于对照组的73.86%，32.95%，9.09%，3.41%，治疗组患者生存期明显长于对照组（P<0.05）。结论：加味八珍汤联合放化疗可以明显提高中晚期宫颈癌患者的机体免疫力，降低血清肿瘤标记物的水平，延长中晚期患者的生存时间，对中晚期宫颈癌具有积极的治疗效果。

Abstract

Objective: To study the clinical efficacy of modified Bazhentang combined with radiotherapy and chemotherapy in treating middle and advanced cervical cancer and investigate its effect on T cell subset

serum tumor markers and survival period. Method: The 177 patients with middle and advanced cervical cancer in our hospital from February 2009 to May 2012

were selected and divided into treatment group (89 cases) and control group (88 cases) according to the random number table. Patients in two groups were treated with radiotherapy and chemotherapy

while the patients in treatment received additional modified Bazhentang. Then the short-term efficacy

T cell subset

serum tumor markers and survival period of the two groups were compared. Result: The total effective rate was 87.64% in treatment group

better than 73.86% in control group (P<0.05). After the treatment

the levels of CD3+

CD4+ and CD4+/CD8+ were significantly increased in both groups

but the level of CD8+was significantly decreased (P<0.05). After the treatment

the levels of CD3+

CD4+ and CD4+/CD8+ in treatment group were significantly higher than those in control group

while the level of CD8+ was significantly lower than that of control group (P<0.05). The expression levels of carbohydrate antigen 125 (CA125)

squamous cell carcinoma associated antigen (SCCA) and carcino-embryonic antigen (CEA) were significantly decreased in both groups after treatment

and the decrease was more obvious in treatment group (P<0.05). The 1

5-year survival rate was 91.01%

55.06%

26.97%

13.48% respectively in treatment group

higher than 73.86%

32.95%

9.09%

3.41% in control group (P<0.05). Conclusion: Modified Bazhentang can significantly improve the immunity

reduce the level of serum tumor markers and prolong the survival time of the patients

so it has positive therapeutic effect on middle and advanced cervical cancer.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Fuzheng Kangai Decoction on Immune Regulation and Inhibition of Tumor Growth in Rats with Ovarian Carcinoma

Effect of Modified Qingzao Jiufei Tang on Quality of Life and Survival Period of Patients with Non-small Cell Lung Cancer

Effect of Modified Renseng Yangrong Tang Combined with Chemotherapy on Serum Tumor Markers and Th1/Th2-type Cytokines Expression in Cervical Cancer Patients

Clinical Observation of Cornu Antelopes Capsule as Adjunctive Therapy for Partial Seizures

Treatment of Fifty-two Patients with Chronic Hepatitis B by Jieyu Ganshu Capsules Plus Adefovir Dipivoxil Tablets

Related Author

Lu TIAN

Xin ZHANG

Yang ZHANG

ZHOU Jian-wei

XIE Li-fang

GU Fang-hong

Li-fang WEN

Jie DING

Related Institution

Affiliated Hospital， Liaoning University of Traditional Chinese Medicine

Qingpu Branch, Zhongshan Hospital Affiliated to Fudan University

Shanxi Fenyang College

Shanxi Fenyang Hospital

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰